CG Oncology, Inc.
Company Stats
- Market Cap
- $6.3B
- as of Sep 30, 2026
- Shares Outstanding
- 88.6M
- Free Float
- 80.4%
Income Statement
- Revenue
- $4.0M
- Operating Income
- -$190.8M
- Net Income
- -$161.0M
- EBITDA
- -$189.3M
Cash Flow
- Free Cash Flow
- -$132.5M
- FCF Yield
- -2.1%
- Owner FCF Yield
- -2.5%
Balance Sheet
- Cash & Equivalents
- $32.5M
Returns & Capital
- SBC, 3Y Avg
- $13.2M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $4.0M | -$132.5M | -3279.2% |
| FY2024 | $1.1M | -$78.9M | -6931.3% |
| FY2023 | $204,000 | — | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 6, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back